Piermont Capital Management’s LifePoint Health, Inc. LPNT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q3
Sell
-33,503
Closed -$1.64M 258
2018
Q2
$1.64M Buy
33,503
+1,790
+6% +$92.7K 0.5% 97
2018
Q1
$1.49M Buy
31,713
+690
+2% +$33.2K 0.5% 94
2017
Q4
$1.54M Hold
31,023
0.51% 93
2017
Q3
$1.8M Hold
31,023
0.59% 81
2017
Q2
$2.08M Sell
31,023
-8,050
-21% -$509K 0.6% 56
2017
Q1
$2.56M Sell
39,073
-3,870
-9% -$239K 0.61% 69
2016
Q4
$2.44M Sell
42,943
-4,030
-9% -$233K 0.56% 72
2016
Q3
$2.78M Buy
+46,973
New +$2.82M 0.66% 54
2016
Q1
Sell
-5,850
Closed -$429K 289
2015
Q4
$429K Sell
5,850
-390
-6% -$27.7K 0.14% 164
2015
Q3
$442K Buy
+6,240
New +$506K 0.14% 157

Other funds holding LPNT

Piermont Capital Management's LPNT Position: Q3 2018 in Review

Piermont Capital Management sold out of LifePoint Health, Inc. (LPNT) in Q3 2018, closing a stake of 33,503 shares — an estimated $1.64M sold.

Piermont Capital Management first reported a position in LPNT in Q3 2015 and held it in 10 quarters. The position peaked at $2.78M in Q3 2016. 223 funds tracked by Wall St. Rank hold LPNT as of Q3 2018.

  • Piermont Capital Management reported no remaining LifePoint Health, Inc. position as of Q3 2018 after selling out during the quarter.
  • Piermont Capital Management sold 33,503 LifePoint Health, Inc. shares in Q3 2018, an estimated $1.64M.
  • Piermont Capital Management first reported a position in LifePoint Health, Inc. in Q3 2015 and held it in 10 quarters.
  • Piermont Capital Management's LifePoint Health, Inc. position peaked at $2.78M in Q3 2016.
  • 223 funds tracked by Wall St. Rank held LifePoint Health, Inc. as of Q3 2018.

Based on Piermont Capital Management's 13F filing for Q3 2018, filed 6 Nov 2018.